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Abstract: Studies on the intestinal epithelial response to viral infection have previously been limited
by the absence of in vitro human intestinal models that recapitulate the multicellular complexity of the
gastrointestinal tract. Recent technological advances have led to the development of “mini-intestine”
models, which mimic the diverse cellular nature and physiological activity of the small intestine.
Utilizing adult or embryonic intestinal tissue, enteroid and organoid systems, respectively, represent
an opportunity to effectively model cellular differentiation, proliferation, and interactions that are
specific to the specialized environment of the intestine. Enteroid and organoid systems represent a
significant advantage over traditional in vitro methods because they model the structure and function
of the small intestine while also maintaining the genetic identity of the host. These more physiologic
models also allow for novel approaches to investigate the interaction of enteric viruses with the
gastrointestinal tract, making them ideal to study the complexities of host-pathogen interactions
in this unique cellular environment. This review aims to provide a summary on the use of human
enteroid and organoid systems as models to study virus pathogenesis.
Keywords: enteroids; organoids; intestinal stem cells; mini-guts; enteroviruses
1. Introduction
The intestinal epithelium is a complex system, with both structural and cellular characteristics
that allow a unique balance between nutrient absorption and crucial host defense. In order to facilitate
adequate fluid and nutrient uptake, the intestinal epithelium forms a lattice-like structure made of
villi and crypts for increased surface area. The single layer of intestinal epithelial cells retains the
absorptive and secretory capabilities while maintaining a rapid cell turnover in order to provide a
physical barrier between the luminal microenvironment and the host. Intestinal stem cells are an
integral driving force in facilitating gut barrier integrity by producing the terminally differentiated
epithelial cell types that compose the intestinal epithelia, including enterocytes, goblet cells, Paneth
cells, and enteroendocrine cells [1–3]. Each of these cell types plays a critical role in host immunity and
defense against pathogens [4,5].
Enteric viruses remain one of the leading causes of acute gastroenteritis among both developing
and developed countries [6]. However, despite their significant impacts on human morbidity and
mortality, there is limited knowledge surrounding many aspects of gastrointestinal (GI) physiology
and viral pathogenesis that occur during viral infections of the GI tract. Conventional in vitro models
have been unsuccessful in investigating some aspects of viral infections of the intestine due to the
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inability of standard cell culture systems to recapitulate the complex environment within the GI tract.
With the development of intestinal enteroid and organoid systems, recent studies have demonstrated
a novel method that models the unique environment of the intestine. This advancement in research
methodology opens new possibilities to study a variety of biological aspects of enteric viruses.
Despite the risk that enteric viruses pose, standard culturing methods have prevented a complete
assessment of many mechanisms utilized by these viruses to infect the intestinal barrier. For example,
difficulties associated with viral propagation in transformed cell lines and/or animal models hindered
norovirus research for many years. Here, we summarize advances in the development of intestinal
enteroids and organoids as well as the differences between these model systems. We also describe
recent literature using these mini-intestine models to study enteric viruses, mainly rotaviruses,
norovirus, adenoviruses and enteroviruses. Although more research is required before effective
therapies may be established for worldwide use, human enteroids and organoids have provided an
exciting new advance to study enteric viral infections in vitro.
2. Defining Gastrointestinal Models
In recent years, the development of mini-intestinal cultures has provided functional in vitro
models with the ability to robustly proliferate and recapitulate basic intestinal morphology.
Due to slight variations between different mini-intestine systems, namely—enteroids and
organoids—nomenclature distinguishing between them has been described by the National Institutes
of Health (NIH) Intestinal Stem Cell Consortium (ISCC). Organoids are defined as a three-dimensional
hollow enterosphere that form a single layer of epithelium with apical-basal polarity that originates
from induced pluripotent stem cells (iPSCs) or embryonic stem cells [7–9]. Another factor specific to
organoids is the underlying mesenchymal cell layer that develops in organoid culture, which is critical
for the maintenance of epithelial tissue identity [7,8,10–13]. The development of organoids follows a
pattern similar to embryonic intestinal development, allowing them to be useful in developmental
studies [8,10–12,14,15]. In contrast, enteroids originate from small intestinal crypt stem cells and
specifically lack mesenchymal cells, such as myofibroblasts, fibroblasts, and stromal cells. Despite
lacking mesenchyme cell types, they retain the ability to proliferate [1,16]. Enteroids represent
mature epithelia, allowing the modeling of homeostasis and the investigation of various disease
mechanisms [11,17–19]. Both enteroids and organoids, represent genetically variable models between
individuals, which allows for disease and susceptibility studies as well as genetic manipulations to
further study disease states [16,18,20,21].
3. Development of Mini-Intestinal Models
3.1. Enteroid Development
Within the last decade, advances in the isolation and maintenance of intestinal stem cells has
allowed the generation and long-term culture of mini-intestines in the laboratory. Sato et al. [1] and
Ootani et al. [22] first described methods to isolate and culture intestinal epithelial stem cells, thus
developing a novel crypt culture system. Hans Clevers and colleagues developed specific conditions
for culturing mouse intestinal crypts including the minimum growth factors required to support
enteroids, specifically R-spondin, epidermal growth factor (EGF) and Noggin [1]. In enteroid culture
systems, the Wnt pathway is the key signaling pathway that promotes stem cell proliferation and
maintains undifferentiated stem cells [23,24]. R-spondin is one of the components that is a necessary
Wnt signaling enhancer [25]. Additionally, EGF plays an integral role in enteroid culture due to
its ability to stimulate intestinal stem cell proliferation [26]. Noggin is another media component
essential for continued passaging of crypt cultures [1]. Noggin has been shown to inhibit bone
morphogenetic protein (BMP) signaling, which restricts the proliferative capacity of stem cells [27,28].
Finally, laminin-rich Matrigel is used as a basement membrane to support the intestinal crypt growth,
since laminin (α1 and α2) are found at high concentrations at the bottom of murine intestinal crypts [29].
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In combination, the above growth factors and laminin-rich Matrigel can support a long-term culture
system of murine intestinal epithelial crypts [1]. With the establishment of the murine intestinal
enteroid systems, studies have been conducted to examine potential limitations of this model. For
instance, Fuller et al. investigated factors such as the age of mice and region of murine intestine [30].
Their study demonstrated that all murine age groups and tissue sections were able to produce enteroids.
Additionally, they determined that mouse intestinal enteroids retain proliferative capacity over time
following cryopreservation, indicating their capability for long-term storage [30].
A key difference between murine enteroids and human enteroids is the requirement of exogenous
Wnt as a growth factor. Since Wnt is endogenously produced at high concentrations by mouse Paneth
cells, exogenous Wnt is not necessarily needed to maintain mouse enteroids; however, this is not the
case for human enteroids, which require Wnt to culture human crypts successfully [31]. Because Wnt
is naturally produced by mouse enteroids, they are less challenging and readily expand in vitro [32].
More recently, an L-cell line was derived to secrete the primary growth factors Wnt3a, R-spondin 3,
and Noggin (L-WRN) as a highly concentrated conditioned medium that has been used to rapidly
expand human intestinal stem cell populations as well as to maintain an undifferentiated progenitor
phenotype in human enteroid cultures [33]. By using an equal mixture of L-WRN conditioned
medium and primary cell culture media, human enteroids exhibit an increase in cell number in ileal
enteroids [33]. The combination of critical growth factors in conditioned media enables enteroid
cultures to proliferate quickly and efficiently. Once cryopreservation was established as a functional
method of storage for human enteroids, Saxena et al. created a human intestinal enteroid bank obtained
from various regions of the intestine including the duodenum, jejunum, and ileum [21]. Overall, the
ability to collect and store intestinal enteroids long-term facilitates further investigation and allows for
modeling of many human intestinal diseases in vitro.
3.2. Organoid Development
The culture of intestinal organoids is temporally associated with growth factor requirements based
on gastrulation and definitive endoderm formation to promote a posterior development [7,8,34,35].
A high concentration of activin A for 3 to 4 days, is required to induce Sox17 and Foxa2, transcription
factors that coordinate the development of the endoderm lineage as reviewed in [36]. As in enteroid
models, activation of the Wnt pathway is of critical importance to promote the development of mouse
embryonic stem cells into a posterior intestinal state. In human organoid models, however, Cao et al.
showed that fibroblast-conditioned medium was required to induce a posterior fate as shown by the
high expression of the colon marker CDX2 [35], through the activation of fibroblast growth factor (FGF)
and Wnt pathways [7,8]. Interestingly, these studies demonstrated that prolonged exposure to FGF
and Wnt for 4 days is necessary to produce an irreversible CDX2 expression and intestinal specification
of human organoids [7]. In line with these findings, it was shown that to promote a posterior human
intestinal organoid development, human iPSCs were exposed to activin A for 3 days, then cultured for
4 days with Wnt3a and FGF4 to induce posterior intestinal specificity, and allowed to grow for 14 to
28 days into intestinal organoids [7,8]. Human iPSCs in this stepwise process of differentiation mimic
the process of embryological development as they become intestinal organoids [7,8,36].
4. Mini-Intestinal Differentiation and Morphology
4.1. Region-Specific Differentiation
The GI tract is divided into multiple segments, each with unique functional properties.
For instance, the duodenum is the only small intestinal segment to express duodenal cytochrome b
reductase (CYBRD1), which is involved in iron metabolism [37]; the jejunum is the main expresser of
lactase phlorizin hydrolase (LCT), which is a disaccharidase that facilitates absorption of lactose [38,39];
and the ileum solely produces the sodium-bile acid transporter (SLC10A2) to facilitate bile acid
absorption [40]. In studies aiming to investigate if region-specific genes are conserved in enteroids,
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Middendorp et al. performed RNA sequencing on villi and crypts from murine intestinal segments
and corresponding murine enteroids [41]. Importantly, the gene expression of mouse enteroids was
similar to those of the in vivo intestinal segments for CYBRD1, LCT, and SLC10A2, respectively [41].
Many of the genes were conserved: duodenum 78% and 43%, jejunum 70% and 65%, and ileum 65%
and 49%, respectively [41]. VanDussen et al. measured gene expression between duodenum, ileum,
and enteroids, as well as rectal tissue and colonoids from humans [33]. In addition, they found that
sucrase-isomaltase (SI) and SLC10A2 were specifically induced in ileal enteroids, which corresponded
to ileal tissue expression [33]. Transient receptor potential cation channel, subfamily V, member 6
(TRPV6) a calcium transport protein, was preferentially expressed in the duodenum and in duodenal
enteroids compared to other intestinal sections and their corresponding enteroids [33,42]. The gene
expression of human rectal tissue and colonoids did not correlate with the gene expression found in
small intestinal tissues nor enteroids. Specific rectal markers such as carbonic anhydrase 1 (CA1) were
only induced in the rectal-derived colonoids and corresponded to in vivo rectal expression [33]. These
studies show that both murine and human enteroids retain a region-specific identity between in vivo
intestinal sections and in vitro enteroid culture [33,41].
Region-specific expression can also be induced in organoid cultures as shown by the directed
differentiation of human iPSCs into intestinal organoids and chronological manipulations of integral
growth factors to simulate the embryonic intestinal development [7]. By using FGF4 and Wnt3a
as growth factors, Spence et al. promoted the formation of colonic organoids identified by the
transcription factors KLF5 and SOX9, two intestinal markers, and CDX2 [7]. In addition, Wang et al.
determined that duodenal, jejunal, and ileal stem cells grown using air-liquid interface culture from
human fetal intestine express genes based on anatomical location [43]. For instance, cultured duodenal
stem cells expressed the genetic markers TFF2 and Muc5AC, which are typical gastric epithelial
markers, while cultured jejunal stem cells expressed intestinal markers, such as Muc2. In the same
way, cultured ileal stem cells resulted in the formation of an epithelium similar to the colon [43]. These
studies demonstrate that organoid development follows region-specific differentiation depending
on tissue source [43] or can be induced to recreate specific regional identity upon growth factor
manipulation [7,43].
4.2. Crypt-Villus Development
In the small intestine, villi function to increase surface area and contain cell types that contribute
to the unique environment of the small intestine. The absorptive and secretory cells of villi arise from
surrounding intestinal crypts (Figure 1), where the proliferative cells of the intestinal epithelium are
located. During in vitro growth of small intestinal enteroids, crypt budding occurs and results in the
development of the crypt-villus axis over time [1]. The crypt-villus axes generated from a developing
enteroid is reminiscent of a mature intestine in an in vitro enteroid culture [1]. Several recent studies
have microengineered scaffolds for the cultivation of enteroids in an attempt to mimic the structure of
the intestine [44–46]. One such study has shown that seeding crypts on an artificial polylactic-glycolic
acid (PLGA)-rich scaffold, can foster the generation of epithelial structures resembling villi both in vitro
and after implantation into small and large animals [44]. Wang et al. demonstrated that a cross-linked
collagen hydrogel supported the proliferation and differentiation of primary human enteroids after
being molded into villi-shaped columns [45]. Additionally, human intestinal enteroids cultured in
the presence of primary intestinal myofibroblasts using a silk-based cylindrical scaffold, were able
to generate a microvilli brush border as well as tight junctions after differentiation [46]. By using
artificially engineered scaffolds, these experiments have shown an ability to produce apical brush
borders, tight junctions, and epithelial cell differentiation into relevant cell types required to recreate
the physiological role of the intestine.
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Figure 1. Cultured enteroid. (A) Photomicrograph demonstrating the architecture of an enteroid; (B) 
Confocal image of an enteroid stained for DAPI (Blue), E-cadherin, an epithelial cell marker (Green), 
and Muc2, a goblet cell marker (Red). Size bars = 50 μm. 
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elucidate if organoids can mature into adult-like tissue [10]. The implanted organoids formed an 
architecture which was similar to adult intestine with villi and a mesenchymal layer, unlike the 
control organoids that lacked a crypt-villus architecture [10]. These studies proposed that organoids 
offer a surrogate method to induce villus formation and that organoids require the mesenchyme and 
vasculature to properly organize epithelial cells into villi.  
A fundamental factor in villus formation relates to peristalsis-like motion, which is difficult to 
recreate in the laboratory setting. Donald Ingber’s group recently demonstrated that this can be 
accomplished in a gut-on-a-chip microfluidic device that has the ability to be subjected to peristalsis-
like mechanical stress [47]. Human primary intestinal epithelium was grown in a microfluidic device 
subjected to a constant flow of media and a vacuum pump. This provides both shear and mechanical 
stress, thus, enabling small intestinal villi-like structures to develop [48]. Strikingly, epithelial cells 
grown in culture without the consistent flow of media did not develop into 3-dimensional villi-like 
formations, but instead maintain a monolayer of differentiated cells [48]. Intestinal enteroid 
fragments cultured in the presence of intestinal microvascular endothelial cells were more confluent 
than cultures of single intestinal stem cells, enteroid fragments, and single intestinal stem cells plus 
the microvascular endothelial cells [48]. Kasendra et al. showed that the gut-on-a-chip using human 
enteroid fragments and intestinal microvascular endothelial cells promote intestinal villi-like 
structures, cell lineage differentiation, epithelial barrier integrity, apical brush borders and resemble 
the adult duodenal transcriptome [48]. These experiments indicate that fluid flow and mechanical 
stress can influence cellular and physical characteristics of progenitor cells in vitro, and the inclusion 
of mesenchymal cells can model the microenvironment in the intestine.  
4.3. Cell Types within Crypts 
The most common cells that reside at the bottom of intestinal crypts are crypt base columnar 
(CBC) cells, interspersed by Paneth cells [49]. In order to identify the specific CBC cells as the 
progenitor for the epithelial cell types found in the intestinal epithelium, Hans Clevers and colleagues 
used leucine-rich repeat-containing G-protein-coupled receptor 5 green fluorescent protein (Lgr5-
GFP) reporter mice to trace the cell lineage of Lgr5+ intestinal stem cells by harvesting murine crypts 
and plating individual cells [1]. In cells expressing the Lgr5 gene, enteroids formed more efficiently, 
while Lgr5− cells did not form enteroids [1]. After two weeks, enteroids from single cells were 
indistinguishable from enteroids derived from whole crypts. Confocal and electron microscopy 
demonstrated that Paneth cells and stem cells occupied the bottom of the crypts, while goblet cells 
and enteroendocrine cells lined the lumen of the enteroids [1]. Notably, there were no mesenchymal 
Figure 1. Cultured enteroid. (A) Photomicrograph demonstrating the architecture of an enteroid;
(B) Confocal image of an enteroid stained for DAPI (Blue), E-cadherin, an epithelial cell marker (Green),
and Muc2, a goblet cell marker (Red). Size bars = 50 µm.
Organoid culture systems provide an alternative method to evaluate the development of
crypt-villus axes. This was shown when human fetal intestinal stem cells produced epithelial folds
after 10 days of air-liquid interface culturing, with duodenum and jejunum producing a finer pattern
of folding than the ileum [43]. By histological examination of the intestinal stem cell culture, villi-like
structures are present with proliferative cells located proximal to the basement membrane with more
pronounced structure forming from the ileum [43]. Thus, air-liquid interface culturing of fetal stem
cells could ultimately maintain the morphological and cellular features of the fetal intestine.
Implanting human intestinal organoids in the kidney capsule of a mouse produced distinct
crypts and villi resembling mature small intestine, suggesting that vasculature along with the host
environment can affect organoid growth [13]. Based off of this previous work, Finkbeiner et al.
implanted approximately 3-week-old human intestinal organoids into immunocompromised mice
to elucidate if organoids can mature into adult-like tissue [10]. The implanted organoids formed
an architecture which was similar to adult intestine with villi and a mesenchymal layer, unlike the
control organoids that lacked a crypt-villus architecture [10]. These studies proposed that organoids
offer a surrogate method to induce villus formation and that organoids require the mesenchyme and
vasculature to properly organize epithelial cells into villi.
A fundamental factor in villus formation relates to peristalsis-like motion, which is difficult
to recreate in the laboratory setting. Donald Ingber’s group recently demonstrated that this can be
accomplished in a gut-on-a-chip microfluidic device that has the ability to be subjected to peristalsis-like
mechanical stress [47]. Human primary intestinal epithelium was grown in a microfluidic device
subjected to a constant flow of media and a vacuum pump. This provides both shear and mechanical
stress, thus, enabling small intestinal villi-like structures to develop [48]. Strikingly, epithelial cells
grown in culture without the consistent flow of media did not develop into 3-dimensional villi-like
formations, but instead maintain a monolayer of differentiated cells [48]. Intestinal enteroid fragments
cultured in the presence of intestinal microvascular endothelial cells were more confluent than cultures
of single intestinal stem cells, enteroid fragments, and single intestinal stem cells plus the microvascular
endothelial cells [48]. Kasendra et al. showed that the gut-on-a-chip using human enteroid fragments
and intestinal microvascular endothelial cells promote intestinal villi-like structures, cell lineage
differentiation, epithelial barrier integrity, apical brush borders and resemble the adult duodenal
transcriptome [48]. These experiments indicate that fluid flow and mechanical stress can influence
cellular and physical characteristics of progenitor cells in vitro, and the inclusion of mesenchymal cells
can model the microenvironment in the intestine.
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4.3. Cell Types within Crypts
The most common cells that reside at the bottom of intestinal crypts are crypt base columnar (CBC)
cells, interspersed by Paneth cells [49]. In order to identify the specific CBC cells as the progenitor for the
epithelial cell types found in the intestinal epithelium, Hans Clevers and colleagues used leucine-rich
repeat-containing G-protein-coupled receptor 5 green fluorescent protein (Lgr5-GFP) reporter mice to
trace the cell lineage of Lgr5+ intestinal stem cells by harvesting murine crypts and plating individual
cells [1]. In cells expressing the Lgr5 gene, enteroids formed more efficiently, while Lgr5− cells did not
form enteroids [1]. After two weeks, enteroids from single cells were indistinguishable from enteroids
derived from whole crypts. Confocal and electron microscopy demonstrated that Paneth cells and
stem cells occupied the bottom of the crypts, while goblet cells and enteroendocrine cells lined the
lumen of the enteroids [1]. Notably, there were no mesenchymal cell types observed. Taken together,
these studies demonstrate that Lgr5+ intestinal stem cells are the progenitor cell for epithelial cell
differentiation [1].
As Lgr5+ intestinal stem cells differentiate, they move upward to occupy the +4 position of the
intestinal crypt, above the Paneth cells, and become transit amplifying (TA) cells that are rapid cycling
precursors to the other terminally differentiated epithelial cell types as reviewed in [50,51]. Recent
evidence has shown that when Lgr5+ stem cells are damaged, specific TA cells such as enterocytes and
secretory progenitors, can trigger crypt regeneration by reverting to a multipotent cell state [3,52,53].
For example, Bmi1+ quiescent endocrine cells, with the help of Paneth cell precursors, are able to
convert to an Lgr5+ intestinal stem cell identity when there is damage to the native Lgr5+ stem cell
population [54]. In addition, TA cells at higher positions in the crypt, position 6 and above, have been
found to restore the loss of Lgr5+ stem cells due to radiation [55].
Of note, Paneth cells are important to the stem cell niche environment, where they produce critical
growth factors for the proliferation and maintenance of Lgr5+ intestinal stem cells [56]. Paneth cells
also secrete a myriad of antimicrobial peptides and proteins, which are crucial for host defense and
the innate immune system [5]. Paneth cells are unique when compared to other intestinal stem cell
lineages as they migrate down into the crypt, instead of up and out of the crypt as the other terminally
differentiated epithelial cells. Rare TA cells that reside in the +4 position and maintain a long S phase
called label-retaining cells are recognized as precursors of terminal Paneth cells [3]. The diversity of
cell types and cellular environments within crypts is one of the hallmark features of enteroid and
organoid modeling that enables a wide variety of experimentation.
5. In Vitro Models to Study Viral Infections
5.1. Human Intestinal Organoids to Model Rotaviral Infections
Rotavirus (RV) is a segmented, double-stranded RNA virus that is one of eight species in the
Reoviridae family [57]. The most common species, Rotavirus A, is the foremost cause of severe
gastroenteritis in children between the ages 2 to 5 worldwide, with 25 to 70 percent leading to
hospitalization [6,58]. Thus, the development of in vitro models that can recapitulate the human
intestine is crucial for expanding current knowledge on RV pathogenesis. Both intestinal enteroids and
organoids have been shown recently to serve as in vitro models to investigate both animal RV (ARV)
and human RV (HRV) infection of the GI tract.
Conventional in vitro methods for culturing RV include propagating the virus into stable cell
lines, such as Rhesus kidney (MA104), human colorectal adenocarcinoma (HT-29 and Caco-2), or into
primary cells, which require multiple passages to reach sufficient growth for analysis [59–63]. With
the development of induced pluripotent stem cells into mini-intestines or human intestinal organoids,
the ability to observe both ARV and HRV infection in a novel model has been demonstrated [21].
Finkbeiner et al. first used human intestinal organoids as in [7,8] to cultivate ARV using Rhesus
rotavirus (RRV; strain G3P[3]) and observed efficient replication by immunofluorescence microscopy
for viral replication factories [64]. This study also found that cleavage of the RRV structural protein 4
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(VP4) by pancreatin, a key digestive enzyme, facilitated RRV infection in epithelial cells, but also in
mesenchymal cells, which had not been previously recognized as a target for RV infection [64].
After establishing that human intestinal organoids support ARV infection, Finkbeiner et al.
explored whether this model could also support HRV replication by using HRV-infected stool [64].
Stool samples collected from Texas Children’s Hospital between 2002 and 2010 were used to inoculate
human intestinal organoids, with active replication of HRV confirmed by assessing the presence of
viral RNA (vRNA) and viroplasms [64]. Importantly, the levels of vRNA generated in human intestinal
organoids were approximately 10 times greater than isolates grown in MA104 cells, indicating that
human intestinal organoids supported better viral growth as compared to immortalized cell lines [64].
Taken together, these data indicate that human intestinal organoids are a more suitable model to
study rotavirus.
5.2. Human Intestinal Enteroids to Model Rotaviral Infection
In testing human intestinal enteroids as a model to culture HRV, Saxena et al. infected human
intestinal enteroids derived from adult duodenal, jejunal, and ileal biopsies with multiple HRV strains
including Ito (G3P[8]) and Wa (G1P[8]) and compared these strains to RRV strain G3P[3] [21]. Strikingly,
based on multiple parallel readouts for viral replication (including flow cytometry, qRT-PCR, electron
microscopy, and immunohistochemistry), the authors observed high levels of HRV infection, with
less robust infection by RRV [21]. Immunofluorescence-based analyses indicated that HRV primarily
infected E-cadherin-positive enterocytes, with infection also identified in chromogranin A-positive
enteroendocrine cells, suggesting that HRVs exhibit a cell-type specificity of infection [21].
Other assays have also been performed in human intestinal enteroids to investigate possible
physiological effects during HRV infections, such as cytotoxicity assays, swelling assays, and enteroid
genotyping. Common in HRV infection, luminal swelling and fluid movement occur during the
diarrheal process. To test if human intestinal enteroids can mimic this process, they were exposed to
the HRV strain Ito and the cross-sectional area was measured via microscopy over several hours [21].
As a result, the lumen of infected human intestinal enteroids expanded between 3 to 4 h post inoculation
(hpi) and reached maximum radius by 6 hpi [21]. Similarly, when exposed to rotaviral enterotoxin
NSP4, which acts via chloride secretion, significant luminal expansion occurred [21]. These results
indicated that human intestinal enteroids are functional and physiologically active in the presence of
HRV infection.
5.3. Cultivating Norovirus in Human Intestinal Enteroids
Human Norovirus (NoV, previously known as “Norwalk-like virus”) is a non-enveloped,
icosahedral, single-stranded RNA virus that remains a significant source of acute gastroenteritis and is
responsible for sporadic community or common-source outbreaks [6,65]. Despite its impact on human
health, little is known regarding NoV infections of the human GI tract due to the inability to propagate
NoVs in previously existing human-based models. Although enteric bacteria were shown to enhance
human NoV infection of B cell lines (M12, WEHI-23, BJAB) [66], it remained unclear whether human
NoVs also replicated in enterocytes or other intestinal-associated cell types. After many attempts by
others to infect cell lines with NoV, the development of human intestinal enteroids has provided an
exciting new model to further study human NoV development, signaling, and pathogenesis. In a study
by Ettayebi et al., the most common genotype of human NoV, GII.4, was derived from fecal filtrates and
inoculated in human intestinal enteroids [67,68]. By 96 hpi, there was a 1.5–2.5 log10 increase in viral
progeny, as indicated by the presence of vRNA. Cytopathic effects, such as cell rounding, destruction
of the monolayer, and an increase in nonviable cells were also observed in GII.4-infected cultures [68].
Further evidence of viral replication was confirmed by immunofluorescence, flow cytometry, and
confocal microscopy. Detection of the enterocyte marker villin in NoV VP1-positive cells confirmed
that enterocytes are the likely primary cell target for human NoV replication [68].
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Human NoV is a genetically diverse pathogen classified into three genotypes: GI, GII, and GIV.
Within these genotypes, they are further divided into 9 GI genotypes and 20 GII genotypes [68]. Studies
have indicated that genetically determined factors, such as secretor status, can influence susceptibility
to certain genotypes of human NoV. Secretor-positive status is indicated by having the active form of
the fucosyltransferase 2 enzyme, which mediates the transfer of fucose onto histoblood group antigen
(HBGA) precursors in GI cells [69]. Ettayebi et al. demonstrated that a GII.4 human NoV strain was
able to infect human enteroids obtained from secretor-positive individuals, yet unable to infect those
from secretor-negative individuals [68]. Furthermore, a GII.3 strain of human NoV was capable of
infecting some, but not all, secretor-negative human enteroids. These data indicate host restriction to
specific genotypes of human NoV.
Environmental factors have also been shown to play a role in NoV infection. In one study, three
strains of human NoVs (GII.3, GII.17, and GI.1) were pretreated with nontoxic doses of human bile,
which is abundant in the small intestine and involved in digestion and absorption [68]. Interestingly,
the authors found that bile was required for NoV infection of human enteroids, whereas untreated
enteroids were not capable of supporting infection [68]. Taken together, these studies support that
human intestinal enteroids, possibly in conjunction with bile, provide a suitable in vitro model of
human NoV infections.
5.4. Enteroids as a Model of Enterovirus Infection
Enteroviruses are a common source of human GI infections transmitted via the fecal-oral
route, yet little is known of their infection pathogenesis within the intestine [62]. In experiments
conducted by Drummond et al., three enteroviruses (coxsackievirus B (CVB), echovirus 11 (E11), and
enterovirus 71 (EV71)) successfully infected human premature intestinal enteroids and resulted in
activation of antiviral signaling pathways [62], previously unobserved in conventional cell line-based
culturing systems. Importantly, this study found that whereas the enteroviruses tested did infect
human enteroids, there were virus type-specific differences in the induction of host antiviral and
pro-inflammatory signaling in response to infection, with E11 inducing the greatest levels of host
defense. Concomitantly, E11 also induced the greatest cytotoxic effect, accompanied by the disruption
of tight junctions, as well as increased levels of high mobility group box 1 (HMGB1), which is associated
with cell necrosis [62]. The authors also found that like HRV and human NoVs, E11 exhibits a cell
type specificity of infection and infected both enterocytes and enteroendocrine cells but did not infect
goblet cells [62]. It is important to note that these studies were performed on enteroids derived from
premature intestine and could have a different phenotype if studies were done on enteroids derived
from the intestine of older patients.
5.5. Enteroid Model of Adenoviral Infection
Enteroid model systems have also been used to elucidate possible viral adaptation to the host
immune system, such as in the case of adenovirus (AdV) [70,71]. Previous research has shown that
while certain serotypes of adenovirus (mouse AdV-1 [70] and human AdV-C [71]) are modulated
by α-defensins (antimicrobial peptides naturally secreted by Paneth cells), other serotypes (mouse
AdV-2 [70] and human AdV-F) [71] are unaffected. In the study by Wilson et al., murine enteroids were
used to observe an increase in enteric infection by mouse AdV-2 when exposed to α-defensins [70].
Using enteroids derived from wild-type (WT) mice and mice lacking functional α-defensins (Mmp7–/–
mice), green fluorescent protein (GFP) tagged mouse AdV-2 (mouse AdV-2. IXeGFP) was microinjected
into the lumen of enteroids and viral infection was measured [70]. Results indicated viral progeny
was 3-fold greater in WT mice compared to Mmp7–/– mice on day 2 and 4-fold greater by day 3 post
infection [70]. Additionally, quantification showed significantly higher levels of GFP-positive enteroids
in WT mice compared to Mmp7–/– mice [70]. Collectively, these data suggest that in specific murine
adenoviral genotypes, α-defensins can facilitate enteric infection. Further studies utilizing human
intestine are required to see whether there are species-specific differences.
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6. Conclusions and Future Directions
While human RV and NoV remain leading causes of acute gastroenteritis, vaccine development
and efficacy are still low. A major barrier in this field is the lack of understanding how these
viruses are identified and interact within a host. Studies have distinguished differences in receptor
recognition between NoV and RV, showing that these viruses interact with HBGAs or with specific
sialic acids, respectively [69,72]. Human HBGAs are highly polymorphic and consist of ABO
(blood group antigens), Lewis, and secretor ligands, which have been suggested to play a role in
pathogen-host interactions. Several studies have explored various genotypes of human RV and
NoV via X-ray crystallography and nuclear magnetic resonance (NMR) to determine the structure
and function of HBGAs in viral infection [69,72]. Human intestinal enteroids and organoids
from individuals expressing a range of HBGAs presents a unique opportunity to study potential
host-pathogen interactions.
While enteroids and organoids can be used to study host immune response, they can also give
insight into the attenuation of virus replication in vitro. In one such study, Saxena et al. tested the
attenuated human RV strain RV1 (used in Rotarix rotavirus vaccine) using human intestinal enteroids
from secretor-negative patients [21]. After multiple attempts, RV1 viral growth consistently replicated
poorly from a secretor-negative patient [21]. In utilizing these in vitro models of the intestine, the
potential for a translational approach towards developing targeted vaccines for RV, NoV, or other
gastroenteritis causing pathogens becomes a possibility.
With the development of novel culture systems to recapitulate the GI tract, the field of enteric
viral research has witnessed many exciting new advances. Notably, these studies have yielded new
in vitro models to propagate human NoV, which can be used to test and develop new antivirals and
have suggested unique mechanisms by which the GI tract might sense and respond to viral infections
in a virus-specific manner. Despite the progress made over the last few years using these in vitro
models, the enteroid and organoid systems provide an incomplete picture of the intestinal defense
mechanisms as they lack the epithelial-immune cell communication, which is known to be a critical
factor in determining the outcome of GI infections. The gut-on-a-chip approach represents an exciting
addition to enteroid and organoid cultures as it can mimic a higher degree of complexity by including
the immune cells to the culture system, offering the possibility to investigate the different potential
interactions occurring at the mucosal surface during a viral infection. Although further research is
required to fully define enteric virus-GI interactions and identify host factors that could be targeted by
antivirals or vaccines, the application of these human models will undoubtedly yield exciting new
insights into a variety of aspects of host-virus interactions in the GI tract.
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